Chemoinformaics analysis of Cannabielsoic-Acid-A
| Molecular Weight | 374.477 | nRot | 6 |
| Heavy Atom Molecular Weight | 344.237 | nRig | 17 |
| Exact Molecular Weight | 374.209 | nRing | 3 |
| Solubility: LogS | -3.582 | nHRing | 1 |
| Solubility: LogP | 5.509 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 60.7538 |
| nHD | 3 | BPOL | 32.7002 |
| QED | 0.507 |
| Synth | 4.18 |
| Natural Product Likeliness | 2.446 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.002 |
| HIA | 0.014 |
| CACO-2 | -4.931 |
| MDCK | 0.0000163 |
| BBB | 0.119 |
| PPB | 0.970866 |
| VDSS | 0.408 |
| FU | 0.0177498 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.85 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.457 |
| CYP2c9-inh | 0.198 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.148 |
| CYP2d6-sub | 0.153 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.137 |
| CL | 1.67 |
| T12 | 0.149 |
| hERG | 0.048 |
| Ames | 0.011 |
| ROA | 0.608 |
| SkinSen | 0.044 |
| Carcinogencity | 0.06 |
| EI | 0.011 |
| Respiratory | 0.88 |
| NR-Aromatase | 0.469 |
| Antiviral | No |
| Prediction | 0.658565 |